Injective (INJ) is currently priced at $3.61, reflecting a 24-hour decline of 1.43%. The daily trading range is relatively narrow at 0.29%, with a high of $3.90 and a low of $3.61 during this period, indicating a lack of significant volatility.

The trading volume stands at approximately 78.7 million, with a volume-to-market cap ratio of 21.80%, suggesting a healthy liquidity environment. However, the short-term moving averages indicate a bearish trend, with the 8 SMA at $3.81 (-5.21%) and the 13 SMA at $3.79 (-4.67%) both pointing downward.

The 1-hour Relative Strength Index (RSI) is at 45, suggesting that INJ is nearing oversold territory, while the 7-day RSI at 54 indicates neutral momentum. Over the past week, INJ has seen a price increase of 10.35%, and its performance over the last 14 and 30 days has been notably strong, with gains of 24.25% and 26.26%, respectively.

Despite the recent dip, the longer-term trends indicate sustained bullishness, especially in the context of the all-time high of $52.62 reached on March 14, 2024. This significant historical price point indicates substantial upside potential, although current price action suggests caution.

Given the mixed signals from technical indicators, the bearish short-term trends combined with strong longer-term momentum lead to a cautious outlook. Therefore, the recommendation for Injective (INJ) is to Hold, allowing for potential price stabilization and reassessment of market conditions before making further trading decisions.